Treatment of Alzheimer's disease. Molecular pathology versus neurotransmitter-based therapy.
Bowen, D M
Treatment of Alzheimer's disease. Molecular pathology versus neurotransmitter-based therapy. [electronic resource] - The British journal of psychiatry : the journal of mental science Sep 1990 - 327-30 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
0007-1250
10.1192/bjp.157.3.327 doi
Aged
Alzheimer Disease--genetics
Amyloid beta-Peptides--genetics
Amyloid beta-Protein Precursor
Cerebral Cortex--pathology
Chromosomes, Human, Pair 21
Cloning, Molecular
Cycloserine--administration & dosage
Glutamates--metabolism
Glutamic Acid
Humans
Neurotransmitter Agents--metabolism
Protease Inhibitors
Protein Precursors--genetics
Receptors, N-Methyl-D-Aspartate--drug effects
Treatment of Alzheimer's disease. Molecular pathology versus neurotransmitter-based therapy. [electronic resource] - The British journal of psychiatry : the journal of mental science Sep 1990 - 327-30 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
0007-1250
10.1192/bjp.157.3.327 doi
Aged
Alzheimer Disease--genetics
Amyloid beta-Peptides--genetics
Amyloid beta-Protein Precursor
Cerebral Cortex--pathology
Chromosomes, Human, Pair 21
Cloning, Molecular
Cycloserine--administration & dosage
Glutamates--metabolism
Glutamic Acid
Humans
Neurotransmitter Agents--metabolism
Protease Inhibitors
Protein Precursors--genetics
Receptors, N-Methyl-D-Aspartate--drug effects